Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-44

First 44 Last

Share
Profile

Follow
Roch2077

10,189 Posts.

1987

09/05/24

16:51

Post #: 73747218
Share

Originally posted by Hawk70: ↑

Yup 'De-Risked' - Christ alive, Nyrada have done the total of ONE trial on 16 mice.

That's it.

This is years away from human trials - and Nyrada alone can't afford one.

The only trial happening is Walter Reed on mice.

And thats to test the validity of the Nyrada one.

Any drug coming from Nyrada is at this stage probably almost a decade away.

This is like saying a spec miner with a promising drill assay is de-risked and worth $1 billion.

There's ramping and then there is blatant untruths.

The SP is 7c now. If you have profit left, take it, and a jump from 2c to 11c on the back of a 16 mouse trial was never going to last.

This is not de-risked. It's not even in the same suburb.

Expand

What you on about years to trial in humans. It’s starts in next 3-4 months

Secondly they have GLP results coming late next month

And yes it is de risked both off current pre clinical study and 2010 preclinical study that derisks the Walter Reed study and future funding

10 million in funding and 10 million market cap. Pretty funny when it’s below the CEO and directors shares coming in next week at 8 cents lol

Funny and easily accumulated

NYR Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MQR

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

LTR

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

First 44 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.0¢		Change 0.010(3.45%)		Mkt cap ! $63.43M

Open	High	Low	Value	Volume
29.0¢	30.0¢	28.0¢	$277.0K	957.1K

Buyers (Bids)

No.	Vol.	Price($)
2	31270	29.5¢

Sellers (Offers)

Price($)	Vol.	No.
30.0¢	130414	1

View Market Depth

No.	Vol.	Price($)
2	31270	0.295
6	261730	0.290
4	75000	0.285
4	100000	0.280
4	77106	0.275

Price($)	Vol.	No.
0.300	130414	1
0.310	59700	2
0.320	5000	1
0.325	75000	1
0.330	7200	1

Last trade - 15.54pm 07/08/2025 (20 minute delay)

NYR (ASX) Chart

Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-44

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-44

Top Stories

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News